Posters

Development of a multiplex test for predicting response to combined immunotherapies in patients with metastatic melanoma

G. Madonna et al., 2022

Exclusive content

Please tell us a bit about yourself to unlock this content.

Unlock content

Related Articles

Optimal Antitumor Immunity is Triggered by WTX-124, a Clinical Stage Conditionally Activated INDUKINE™ Molecule that Releases Fully Potent IL-2 into the Tumor Microenvironment

Posted on 01 Nov 2023

Read Post
Profiling Cytokeratins in the Tumor Microenvironment Using Multiplex Immunofluorescence

Posted on 01 Nov 2023

Read Post